- Home
- MHUA vs NEPH Comparison
MHUA vs NEPH Comparison
Compare MHUA & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- NEPH
- Stock Information
- Founded
- MHUA 1990
- NEPH 1997
- Country
- MHUA China
- NEPH United States
- Employees
- MHUA N/A
- NEPH N/A
- Industry
- MHUA Medical Specialities
- NEPH Medical/Dental Instruments
- Sector
- MHUA Health Care
- NEPH Health Care
- Exchange
- MHUA Nasdaq
- NEPH Nasdaq
- Market Cap
- MHUA 19.6M
- NEPH 16.8M
- IPO Year
- MHUA 2022
- NEPH 2004
- Fundamental
- Price
- MHUA $0.41
- NEPH $5.00
- Analyst Decision
- MHUA
- NEPH Buy
- Analyst Count
- MHUA 0
- NEPH 1
- Target Price
- MHUA N/A
- NEPH $5.00
- AVG Volume (30 Days)
- MHUA 245.9K
- NEPH 63.1K
- Earning Date
- MHUA 04-25-2025
- NEPH 08-07-2025
- Dividend Yield
- MHUA N/A
- NEPH N/A
- EPS Growth
- MHUA N/A
- NEPH N/A
- EPS
- MHUA 0.40
- NEPH 0.08
- Revenue
- MHUA $96,909,642.00
- NEPH $15,517,000.00
- Revenue This Year
- MHUA N/A
- NEPH $17.06
- Revenue Next Year
- MHUA N/A
- NEPH $12.20
- P/E Ratio
- MHUA $1.03
- NEPH $65.85
- Revenue Growth
- MHUA N/A
- NEPH 10.34
- 52 Week Low
- MHUA $0.25
- NEPH $1.36
- 52 Week High
- MHUA $1.47
- NEPH $5.00
- Technical
- Relative Strength Index (RSI)
- MHUA 49.99
- NEPH 75.40
- Support Level
- MHUA $0.30
- NEPH $3.29
- Resistance Level
- MHUA $0.41
- NEPH $4.20
- Average True Range (ATR)
- MHUA 0.08
- NEPH 0.49
- MACD
- MHUA -0.01
- NEPH 0.06
- Stochastic Oscillator
- MHUA 32.09
- NEPH 100.00
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.